2753650-84-7
Chemical Structure
(Rac)-GDC-2992
Synonym(s): (Rac)-RO7656594; PROTAC AR Degrader-6
- CAS. Nr.: 2753650-84-7
- Formula:C45H51ClN8O5
- Molecular Weight:819.39
InChIKey: PAELKDHSDBUTGE-OEYVUBRSSA-N
SMILES: CC(C)([C@H](C1(C)C)NC(C2=CC=C(N3CCC(CC3)CN4CCN(C5=CC=C(C(N(C6C(NC(CC6)=O)=O)N=C7)=O)C7=C5)CC4)C=C2)=O)[C@H]1OC8=CC(Cl)=C(C=C8)C#N
Biological Activity: (Rac)-GDC-2992 ((Rac)-RO7656594; PROTAC AR Degrader-6) (Compound 1) is an androgen receptor (AR) PROTAC degrader with a DC50 of 10 nM in VCaP cells. (Rac)-GDC-2992 blocks androgen receptor-mediated signaling processes and also degrades the receptor itself. (Rac)-GDC-2992 can be used in prostate cancer research, including studies on castration-resistant prostate cancer and metastatic castration-resistant prostate cancer[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(Rac)-GDC-2992 | (Rac)-GDC-2992 ((Rac)-RO7656594; PROTAC AR Degrader-6) (Compound 1) is an androgen receptor (AR) PROTAC degrader with a DC50 of 10 nM in VCaP cells. (Rac)-GDC-2992 blocks androgen receptor-mediated signaling processes and also degrades the receptor itself. (Rac)-GDC-2992 can be used in prostate cancer research, including studies on castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
